₹ 1,881.60
62.60 (3.44%)
NSE
B
Beta Drugs
₹ 1,881.60
NSE
BETA Financials Summary (Consolidated)
Beta Drugs revenue increased 9.52% quarter-on-quarter to ₹139 Cr in Sep 2026, while net profit increased 16.97% quarter-on-quarter to ₹19 Cr. Compared to the same quarter last year, revenue is up 30.83% and net profit is up 58.20%. EPS for the quarter stood at ₹16.59, increased from ₹14.78 in the previous quarter and up from ₹12.10 a year ago.
Beta Drugs Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of BETA Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
BETA Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






